The FDA has approved Skinvive by Juvéderm for improvement of neck appearance, marking the first indication outside facial rejuvenation for AbbVie's hyaluronic acid filler platform. The product is positioned as a smooth, injectable gel designed to address neck lines and skin texture — a clinical gap many practices have managed off-label or deferred to energy devices.